# Lineage Cell Therapeutics, Inc.: Form SC 13D/A, filed Nov 21, 2024

- Company: [Lineage Cell Therapeutics, Inc.](/companies/lctx.md) (CIK 876343)
- Form: SC 13D/A
- Filed: 2024-11-21
- Accepted by EDGAR: Nov 21, 2024, 20:05 ET
- Period: not reported
- Accession: 0000919574-24-006855
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/876343/000091957424006855/d11534381_13d-a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/876343/000091957424006855/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/876343/000091957424006855/d11534381_13d-a.htm

Filed Nov 21, 2024.
Source: SEC EDGAR, the filing index for accession 0000919574-24-006855. Last ingested by Listed: Oct 24, 2026, 14:58 ET. No prices; not investment advice.